Thursday, September 22, 2022 11:48:04 AM
"They couldn't prove to the judge for a default motion and wont be able to prove it to a jury either."
The SEC did have a summary judgement granted for 2 of the claims and 2 are going to trial.
"The Court denied the Commission's motion as to its claim that Deitsch aided and abetted Nutra Pharma's failure to file these required Forms 8-K, leaving that claim along with the Commission's fraud claims for resolution at trial."
"The Court found Nutra Pharma and Deitsch violated Sections 5(a) and (c) of the Securities Act of 1933 through their unregistered offering of securities; that Nutra Pharma violated Section 13(a) of the Exchange Act of 1934 ("Exchange Act") and Rule 13a-11 thereunder for failing to file required Forms 8-K related to stock issuances; and that Deitsch violated Exchange Act Sections 13(d)(1) and 16(a) and Rules 13d-2(a) and 16a-3 thereunder by failing to make required filings about his beneficial ownership."
Deitsch is finished.
IG
The First Casualty of Emotion is Reason.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM